VRK2 and depressive symptom measurement: In addition, GWAS studies have shown associations between VRK2 and size of the cerebral cortex, epilepsy, depression, bipolar disorder, anorexia nervosa, schizophrenia, autism spectrum disorder, and post-traumatic stress disorder (S2 Table).